Ayu Devices is a medical-device startup based in India, spun out of IIT Bombay, that makes the AyuSynk digital stethoscope module for doctors and clinicians.

This Startup Deep Dive explains what Ayu Devices does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Ayu Devices in Brief

• What it is: Ayu Devices is an Indian Digital stethoscope medtech company based in Mumbai (reports differ: one listing says Bengaluru).
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• The company makes AyuSynk, a module that attaches to a conventional stethoscope to amplify heart and lung sounds, filter noise, record and visualise them.
• Sounds can be streamed over Bluetooth to earbuds or to a remote consultant, which supports tele-auscultation.
• A phonocardiogram can be displayed on a smartphone or laptop.
• Funding: Reports differ: one aggregator lists about $2.24 million across 6 rounds, another lists no known external funding.

Ayu Devices Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Ayu Devices?

Ayu Devices operates in the Digital stethoscope medtech space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Ayu Devices.

• The company makes AyuSynk, a module that attaches to a conventional stethoscope to amplify heart and lung sounds, filter noise, record and visualise them.
• Sounds can be streamed over Bluetooth to earbuds or to a remote consultant, which supports tele-auscultation.
• A phonocardiogram can be displayed on a smartphone or laptop.
• It targets B2B buyers such as telemedicine centres and hospitals, and B2C buyers such as medical students and doctors.

The Origin Story of Ayu Devices

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Adarsha K, Rupesh Ghyar, Tapas Pandey.
• Three IIT Bombay researchers started at MEDIC, a five-day hackathon run by the BETiC incubation centre, where they built a way to transfer heart and lung sounds.
• A BETiC professor then offered a fellowship to turn it into a product, and they left their jobs.
• The company was spun out of BETiC and incubated at SINE, IIT Bombay, from 2017.
• Reports differ on co-founders: most listings name Adarsha K, Rupesh Ghyar and Tapas Pandey; one aggregator adds Vikas Kumar, and a Shark Tank coverage piece names Adarsh Kachappilly, Tapas Pandey and Varad Patil.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Digital stethoscope medtech sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2017: incubated at SINE, IIT Bombay; Biotechnology Ignition Grant of Rs 5 million reported.
• 2018: device priced at about Rs 11,000 versus Rs 25,000 to Rs 50,000 for imported digital stethoscopes (2018 article).
• 2020: BIRAC Fastrack Fund for COVID-19; AyuSynk listed in a government COVID-19 innovation listing for isolation-ward use.
• 2021 (reported): over 4,000 units deployed across India, including Sir JJ Hospital and KEM Hospital in Mumbai.
• January 2023: pitched on Shark Tank India Season 2; one source records Rs 50 lakh for 3.5% equity plus a Rs 50 lakh loan at 10% interest from Namita Thapar, while another snippet reports a different split (sources differ).

Ayu Devices Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Reported: Biotechnology Ignition Grant (2017, Rs 5 million) and BIRAC Fastrack Fund for COVID-19 (2020), amounts of the second not stated.
• SINE invested Rs 500,000 and offered another Rs 3 million for a larger stake (2018 article).
• Shark Tank India S2 (aired January 2023): reported Rs 50 lakh for 3.5% equity plus Rs 50 lakh debt at 10% (one source).
• Reported by one aggregator: about $2.24 million across 6 rounds with investors including IIT Bombay, Enrission India Capital and SINE; another aggregator shows no known external funding.

How Does Ayu Devices Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• The company sells the AyuSynk device to hospitals and clinicians.
• Keeping the traditional stethoscope look while adding digital features is the pitch against fully digital rivals.
• Targets both institutional buyers such as telemedicine centres and individual doctors and students.

The Numbers: Ayu Devices Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• A 2018 article cited a target of 1,000 units sold by the end of FY19.

Market Opportunity for Ayu Devices

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• The 2018 article cited about 900,000 doctors in India, 50,000 new medical students a year and 105 telemedicine centres.
• Cardiovascular disease causes around 1.7 million deaths a year in India, per the same article.
• Company-stated: plans to expand into the UK, Europe and the US.

Technology and Product at Ayu Devices

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Digital signal capture and phonocardiogram display on a smartphone or laptop.

Team and Culture at Ayu Devices

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Adarsha K is described as CEO and co-founder.
• Rupesh Ghyar is listed as a director/co-founder.

Ayu Devices Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Ayu Devices

• Competitors range from cheaper local devices to global medical device firms.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.
• Data privacy risk: health records are sensitive, and breaches or misuse can bring legal and reputational harm.
• Thin margins: low-ticket services and heavy customer-acquisition spend can keep unit economics weak.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Ayu Devices Growth Outlook: What to Watch

• Company-stated: plans to expand into the UK, Europe and the US, with about 20% growth forecast (2021 article).
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Ayu Devices can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Ayu Devices Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Ayu Devices

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Ayu Devices.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Ayu Devices

Studying a company in the Digital stethoscope medtech space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Ayu Devices.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Ayu Devices as a Startup

• Customer clarity: Can Ayu Devices name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Ayu Devices is part of India’s growing Digital stethoscope medtech ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Ayu Devices FAQs: Frequently Asked Questions

What is Ayu Devices?

Ayu Devices is a medical-device startup based in India, spun out of IIT Bombay, that makes the AyuSynk digital stethoscope module for doctors and clinicians. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Ayu Devices?

Ayu Devices was founded by Adarsha K, Rupesh Ghyar, Tapas Pandey, and the company reports a founding year of 2017.

How much funding has Ayu Devices raised?

Reports differ: one aggregator lists about $2.24 million across 6 rounds, another lists no known external funding. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Ayu Devices make money?

Ayu Devices earns revenue from its Digital stethoscope medtech products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Ayu Devices?

Reported rivals include MUSEinc (Taal), 3M, Medline Industries, Rudolf Riester. See the competitor comparison above for how they differ.

What are the main risks for Ayu Devices?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Strand Life Sciences — Strand Life Sciences: Reliance bought control for Rs 393 Cr | Wealth Desk — WealthDesk: WealthBaskets platform reportedly bought by PhonePe. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.